Alison T Stopeck

  • 10991 Citations
  • 41 h-Index
1982 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2019

A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer

Segar, J. M., Reed, D., Stopeck, A. T., Livingston, R. B. & Chalasani, P., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Open Access

Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

Stopeck, A. T., Brufsky, A., Kennedy, L., Bhatta, S., Bhowmik, D., Buchanan, J., Despiegel, N. & Hechmati, G., Jan 1 2019, (Accepted/In press) In : Journal of medical economics.

Research output: Contribution to journalArticle

Open Access
2018

Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer

Kaufman, P. A., Wildiers, H., Freyer, G., Kemeny, M., Gonçalves, A., Jerusalem, G., Stopeck, A. T., Vrindavanam, N., Dalenc, F., Nanayakkara, N., Wu, B. & Pickett, C. A., Jan 1 2018, (Accepted/In press) In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

2 Scopus citations

Reproducible automated breast density measure with no ionizing radiation using fat-water decomposition MRI

Ding, J., Stopeck, A. T., Gao, Y., Marron, M. T., Wertheim, B. C., Altbach, M. I., Galons, J-P., Roe, D., Wang, F., Maskarinec, G., Thomson, C., Thompson, P. A. & Huang, C., Jan 1 2018, (Accepted/In press) In : Journal of Magnetic Resonance Imaging.

Research output: Contribution to journalArticle

5 Scopus citations
2017

A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen

Thomson, C., Chow, H-H., Wertheim, B. C., Roe, D., Stopeck, A. T., Maskarinec, G., Altbach, M. I., Chalasani, P., Huang, C., Strom, M. B., Galons, J-P. & Thompson, P. A., May 30 2017, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-11 11 p.

Research output: Contribution to journalArticle

8 Scopus citations
154 Scopus citations
2016

A maximum-likelihood method to estimate a single ADC value of lesions using diffusion MRI

Jha, A. K., Rodriguez, J. J. & Stopeck, A. T., 2016, (Accepted/In press) In : Magnetic Resonance in Medicine.

Research output: Contribution to journalArticle

4 Scopus citations

Changes in bone turnover marker levels and clinical outcomes in patients with advanced cancer and bone metastases treated with bone antiresorptive agents

Lipton, A., Smith, M. R., Fizazi, K., Stopeck, A. T., Henry, D., Brown, J. E., Shore, N. D., Saad, F., Spencer, A., Zhu, L. & Warner, D. J., Dec 1 2016, In : Clinical Cancer Research. 22, 23, p. 5713-5721 9 p.

Research output: Contribution to journalArticle

11 Scopus citations

Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer

Brown-Glaberman, U., Marron, M., Chalasani, P., Livingston, R. B., Iannone, M. E., Specht, J. & Stopeck, A. T., 2016, In : Disease Markers. 2016, 9810383.

Research output: Contribution to journalArticle

7 Scopus citations

Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics

Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Smith, M. R., Shore, N., Martin, M., Vadhan-Raj, S., Brown, J. E., Richardson, G. E., Saad, F., Yardley, D. A., Zhou, K., Balakumaran, A. & Braun, A., Jan 1 2016, In : European Journal of Cancer. 53, p. 75-83 9 p.

Research output: Contribution to journalArticle

47 Scopus citations

Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]

Stopeck, A. T., Fizazi, K., Body, J. J., Brown, J. E., Carducci, M., Diel, I., Fujiwara, Y., Martín, M., Paterson, A., Tonkin, K., Shore, N., Sieber, P., Kueppers, F., Karsh, L., Yardley, D., Wang, H., Maniar, T., Arellano, J. & Braun, A., Jan 1 2016, In : Supportive Care in Cancer. 24, 1, p. 457-458 2 p.

Research output: Contribution to journalArticle

17 Scopus citations

Extending aromatase-inhibitor adjuvant therapy to 10 years

Goss, P. E., Ingle, J. N., Pritchard, K. I., Robert, N. J., Muss, H., Gralow, J., Gelmon, K., Whelan, T., Strasser-Weippl, K., Rubin, S., Sturtz, K., Wolff, A. C., Winer, E., Hudis, C., Stopeck, A. T., Beck, J. T., Kaur, J. S., Whelan, K., Tu, D. & Parulekar, W. R., Jul 21 2016, In : New England Journal of Medicine. 375, 3, p. 209-219 11 p.

Research output: Contribution to journalArticle

252 Scopus citations

Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases

von Moos, R., Body, J. J., Egerdie, B., Stopeck, A. T., Brown, J., Fallowfield, L., Patrick, D. L., Cleeland, C., Damyanov, D., Palazzo, F. S., Marx, G., Zhou, Y., Braun, A., Balakumaran, A. & Qian, Y., Mar 1 2016, In : Supportive Care in Cancer. 24, 3, p. 1327-1337 11 p.

Research output: Contribution to journalArticle

32 Scopus citations

Pathophysiology of tumour-induced microangiopathic haemolytic anaemia

Chalasani, P., Segar, J. M., Marron, M. & Stopeck, A. T., Jan 7 2016, In : BMJ Case Reports. 2016, 213521.

Research output: Contribution to journalArticle

1 Scopus citations

Phase II study of metformin for reduction of obesity-associated breast cancer risk: A randomized controlled trial protocol

Martinez, J. A., Chalasani, P., Thomson, C., Roe, D., Altbach, M. I., Galons, J-P., Stopeck, A. T., Thompson, P. A., Villa-Guillen, D. E. & Chow, H-H., Jul 19 2016, In : BMC Cancer. 16, 1, 500.

Research output: Contribution to journalArticle

13 Scopus citations

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

Stopeck, A. T., Fizazi, K., Body, J. J., Brown, J. E., Carducci, M., Diel, I., Fujiwara, Y., Martín, M., Paterson, A., Tonkin, K., Shore, N., Sieber, P., Kueppers, F., Karsh, L., Yardley, D., Wang, H., Maniar, T., Arellano, J. & Braun, A., Jan 1 2016, In : Supportive Care in Cancer. 24, 1, p. 447-455 9 p.

Research output: Contribution to journalArticle

45 Scopus citations
2015

A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer

Chalasani, P., Marron, M., Roe, D., Clarke, K., Iannone, M. E., Livingston, R. B., Shan, J. S. & Stopeck, A. T., Jul 1 2015, In : Cancer Medicine. 4, 7, p. 1051-1059 9 p.

Research output: Contribution to journalArticle

18 Scopus citations

Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models

Chen, L. Q., Howison, C. M., Spier, C., Stopeck, A. T., Malm, S. W., Pagel, M. D. & Baker, A. F., May 1 2015, In : Leukemia and Lymphoma. 56, 5, p. 1432-1439 8 p.

Research output: Contribution to journalArticle

18 Scopus citations

Automated Breast Segmentation of Fat and Water MR Images Using Dynamic Programming

Rosado-Toro, J. A., Barr, T., Galons, J. P., Marron, M. T., Stopeck, A., Thomson, C., Thompson, P., Carroll, D., Wolf, E., Altbach, M. I. & Rodríguez, J. J., Feb 1 2015, In : Academic radiology. 22, 2, p. 139-148 10 p.

Research output: Contribution to journalArticle

25 Scopus citations

Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver Metastasis

Stephen, R. M., Jha, A. K., Roe, D. J., Trouard, T. P., Galons, J. P., Kupinski, M. A., Frey, G., Cui, H., Squire, S., Pagel, M. M., Rodriguez, J. J., Gillies, R. J. & Stopeck, A. T., Dec 1 2015, In : Magnetic Resonance Imaging. 33, 10, p. 1267-1273 7 p.

Research output: Contribution to journalArticle

8 Scopus citations

EMERGE: A randomized phase II study of the antibody-drug conjugate glembatumumab vedotin in advanced glycoprotein NMB - Expressing breast cancer

Yardley, D. A., Weaver, R., Melisko, M. E., Saleh, M. N., Arena, F. P., Forero, A., Cigler, T., Stopeck, A., Citrin, D., Oliff, I., Bechhold, R., Loutfi, R., Garcia, A. A., Cruickshank, S., Crowley, E., Green, J., Hawthorne, T., Yellin, M. J., Davis, T. A. & Vahdat, L. T., May 10 2015, In : Journal of Clinical Oncology. 33, 14, p. 1609-1619 11 p.

Research output: Contribution to journalArticle

79 Scopus citations

Hypocalcaemia in patients with metastatic bone disease treated with denosumab

Body, J. J., Bone, H. G., De Boer, R. H., Stopeck, A. T., Van Poznak, C., Damião, R., Fizazi, K., Henry, D. H., Ibrahim, T., Lipton, A., Saad, F., Shore, N., Takano, T., Shaywitz, A. J., Wang, H., Bracco, O. L., Braun, A. & Kostenuik, P. J., Aug 8 2015, In : European Journal of Cancer. 51, 13, p. 1812-1821 10 p., 9488.

Research output: Contribution to journalArticle

54 Scopus citations

Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series

Chahal, J., Stopeck, A. T., Clarke, K., Livingston, R. B. & Chalasani, P., Sep 27 2015, In : Neurological Sciences. 36, 9, p. 1691-1693 3 p.

Research output: Contribution to journalArticle

7 Scopus citations

The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease

Diel, I. J., Body, J. J., Stopeck, A. T., Vadhan-Raj, S., Spencer, A., Steger, G., Von Moos, R., Goldwasser, F., Feng, A. & Braun, A., 2015, In : European Journal of Cancer. 51, 11, p. 1467-1475 9 p.

Research output: Contribution to journalArticle

21 Scopus citations
2014
11 Scopus citations

Isolation of viable cancer cells in antibody-functionalized microfluidic devices

Zheng, X., Jiang, L., Schroeder, J., Stopeck, A. T. & Zohar, Y., Mar 1 2014, In : Biomicrofluidics. 8, 2, 24119.

Research output: Contribution to journalArticle

8 Scopus citations

Recombinant factor VIIa analog in the management of hemophilia with inhibitors: Results from a multicenter, randomized, controlled trial of vatreptacog alfa

Lentz, S. R., Ehrenforth, S., Abdul Karim, F., Matsushita, T., Weldingh, K. N., Windyga, J., Mahlangu, J. N., Weltermann, A., de Paula, E., Cerqueira, M., Zupancic-Salek, S., Katsarou, O., Economou, M., Nemes, L., Boda, Z., Santagostino, E., Tagariello, G., Hanabusa, H., Fukutake, K., Taki, M. & 33 others, Shima, M., Gorska-Kosicka, M., Serban, M., Andreeva, T., Savic, A., Elezovic, I., Mahlangu, J., Tsay, W., Shen, M., Chuansumrit, A., Angchaisuksiri, P., Kavakli, K., Kupesiz, A., Sasmaz, I., Madan, B., Rangarajan, S., Giangrande, P., Saxena, K., Lentz, S., Recht, M., Kempton, C., Barrett, J., Young, G., Quon, D., Stopeck, A., Lin, J., Ameri, A., Kaicker, S., Kuriakose, P., Obzut, D., Wang, M., Ortiz, I. & Sori, A., Aug 2014, In : Journal of Thrombosis and Haemostasis. 12, 8, p. 1244-1253 10 p.

Research output: Contribution to journalArticle

44 Scopus citations
2013

Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: Integrated results from three randomized, double-blind studies of denosumab and zoledronic acid

Von Moos, R., Body, J. J., Egerdie, B., Stopeck, A., Brown, J. E., Damyanov, D., Fallowfield, L. J., Marx, G., Cleeland, C. S., Patrick, D. L., Palazzo, F. G., Qian, Y., Braun, A. & Chung, K., Dec 2013, In : Supportive Care in Cancer. 21, 12, p. 3497-3507 11 p.

Research output: Contribution to journalArticle

53 Scopus citations

Pain outcomes in patients with advanced breast cancer and bone metastases: Results from a randomized, double-blind study of denosumab and zoledronic acid

Cleeland, C. S., Body, J. J., Stopeck, A., Von Moos, R., Fallowfield, L., Mathias, S. D., Patrick, D. L., Clemons, M., Tonkin, K., Masuda, N., Lipton, A., De Boer, R., Salvagni, S., Oliveira, C. T., Qian, Y., Jiang, Q., Dansey, R., Braun, A. & Chung, K., Feb 15 2013, In : Cancer. 119, 4, p. 832-838 7 p.

Research output: Contribution to journalArticle

85 Scopus citations

Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases

Matza, L. S., Cong, Z., Chung, K., Stopeck, A., Tonkin, K., Brown, J., Braun, A., Van Brunt, K. & McDaniel, K., Jan 1 2013, In : Patient Preference and Adherence. 7, p. 855-865 11 p.

Research output: Contribution to journalArticle

14 Scopus citations
2012
45 Scopus citations

Bone-related complications and quality of life in advanced breast cancer: Results from a randomized phase III trial of denosumab versus zoledronic acid

Martin, M., Bell, R., Bourgeois, H., Brufsky, A., Diel, I., Eniu, A., Fallowfield, L., Fujiwara, Y., Jassem, J., Paterson, A. H. G., Ritchie, D., Steger, G. G., Stopeck, A., Vogel, C., Fan, M., Jiang, Q., Chung, K., Dansey, R. & Braun, A., Sep 1 2012, In : Clinical Cancer Research. 18, 17, p. 4841-4849 9 p.

Research output: Contribution to journalArticle

65 Scopus citations

Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

Stopeck, A., Rader, M., Henry, D., Danese, M., Halperin, M., Cong, Z., Qian, Y., Dansey, R. & Chung, K., Aug 1 2012, In : Journal of medical economics. 15, 4, p. 712-723 12 p.

Research output: Contribution to journalArticle

43 Scopus citations

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases

Saad, F., Brown, J. E., Van Poznak, C., Ibrahim, T., Stemmer, S. M., Stopeck, A. T., Diel, I. J., Takahashi, S., Shore, N., Henry, D. H., Barrios, C. H., Facon, T., Senecal, F., Fizazi, K., Zhou, L., Daniels, A., Carrière, P. & Dansey, R., May 1 2012, In : Annals of Oncology. 23, 5, p. 1341-1347 7 p.

Research output: Contribution to journalArticle

371 Scopus citations

Prevalence of depression in adults with haemophilia

Iannone, M., Pennick, L., Tom, A., Cui, H., Gilbert, M., Weihs, K. & Stopeck, A. T., Nov 1 2012, In : Haemophilia. 18, 6, p. 868-874 7 p.

Research output: Contribution to journalArticle

32 Scopus citations

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials

Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Brown, J. E., Yardley, D. A., Richardson, G. E., Siena, S., Maroto, P., Clemens, M., Bilynskyy, B., Charu, V., Beuzeboc, P., Rader, M., Viniegra, M., Saad, F., Ke, C., Braun, A. & Jun, S., Nov 1 2012, In : European Journal of Cancer. 48, 16, p. 3082-3092 11 p.

Research output: Contribution to journalArticle

318 Scopus citations

Task-based evaluation of segmentation algorithms for diffusion-weighted MRI without using a gold standard

Jha, A. K., Kupinski, M. A., Rodríguez, J. J., Stephen, R. M. & Stopeck, A. T., Jul 7 2012, In : Physics in medicine and biology. 57, 13, p. 4425-4446 22 p.

Research output: Contribution to journalArticle

12 Scopus citations

The role of targeted therapy and biomarkers in breast cancer treatment

Stopeck, A. T., Brown-Glaberman, U., Wong, H. Y., Park, B. H., Barnato, S. E., Gradishar, W. J., Hudis, C. A. & Rugo, H. S., Oct 1 2012, In : Clinical and Experimental Metastasis. 29, 7, p. 807-819 13 p.

Research output: Contribution to journalArticle

29 Scopus citations

Weighing bone-targeted treatment options for patients with solid tumours and skeletal complications from metastatic disease

Fallowfield, L., von Moos, R., Costa, L., Stopeck, A., Clemons, M., Clarke, N., Braun, A. & Chung, K., Jul 1 2012, In : European Oncology and Haematology. 8, 3, p. 148-155 8 p.

Research output: Contribution to journalArticle

3 Scopus citations
2011

Decreased bone mineral density in adult patients with Hemophilia: Clinical significance, prevalence and risk factors

Broum-Glaberman, U., Kissee, M. C., Damiano, M. L., Roe, D. J. & Stopeck, A. T., Oct 1 2011, In : Journal of Coagulation Disorders. 3, 1, p. 27-33 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

HSP90 inhibition is effective in breast cancer: A phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab

Modi, S., Stopeck, A., Linden, H., Solit, D., Chandarlapaty, S., Rosen, N., D'Andrea, G., Dickler, M., Moynahan, M. E., Sugarman, S., Ma, W., Patil, S., Norton, L., Hannah, A. L. & Hudis, C., Aug 1 2011, In : Clinical Cancer Research. 17, 15, p. 5132-5139 8 p.

Research output: Contribution to journalArticle

287 Scopus citations

Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors

Gerber, D. E., Stopeck, A. T., Wong, L., Rosen, L. S., Thorpe, P. E., Shan, J. S. & Ibrahim, N. K., Nov 1 2011, In : Clinical Cancer Research. 17, 21, p. 6888-6896 9 p.

Research output: Contribution to journalArticle

45 Scopus citations

Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer

Rugo, H. S., Stopeck, A. T., Joy, A. A., Chan, S., Verma, S., Lluch, A., Liau, K. F., Kim, S., Bycott, P., Rosbrook, B., Bair, A. H. & Soulieres, D., Jun 20 2011, In : Journal of Clinical Oncology. 29, 18, p. 2459-2465 7 p.

Research output: Contribution to journalArticle

86 Scopus citations

Systemic treatment of early breast cancer - A biological perspective

Greenberg, S., Stopeck, A. & Rugo, H. S., May 1 2011, In : Journal of Surgical Oncology. 103, 6, p. 619-626 8 p.

Research output: Contribution to journalArticle

6 Scopus citations
2010
11 Scopus citations

Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate diets

Thomson, C. A., Stopeck, A. T., Bea, J. W., Cussler, E., Nardi, E., Frey, G. & Thompson, P. A., Nov 1 2010, In : Nutrition and cancer. 62, 8, p. 1142-1152 11 p.

Research output: Contribution to journalArticle

43 Scopus citations

Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: A randomized, double-blind study

Stopeck, A. T., Lipton, A., Body, J. J., Steger, G. G., Tonkin, K., De Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., Fan, M., Jiang, Q., Dansey, R., Jun, S. & Braun, A., Dec 10 2010, In : Journal of Clinical Oncology. 28, 35, p. 5132-5139 8 p.

Research output: Contribution to journalArticle

978 Scopus citations

Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I Trial

Thompson, P. A., Hsu, C. H., Green, S., Stopeck, A. T., Johnson, K., Alberts, D. S. & Chow, H. H. S., Jan 1 2010, In : Cancer Prevention Research. 3, 1, p. 101-107 7 p.

Research output: Contribution to journalArticle

5 Scopus citations
2009

A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108

Stopeck, A. T., Unger, J. M., Rimsza, L. M., Bellamy, W. T., Iannone, M., Persky, D., Leblanc, M., Fisher, R. & Miller, T., Aug 17 2009, In : Leukemia and Lymphoma. 50, 5, p. 728-735 8 p.

Research output: Contribution to journalArticle

82 Scopus citations

Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy.

Thomson, C. A., Thompson, P. A., Wright-Bea, J., Nardi, E., Frey, G. R. & Stopeck, A., Dec 2009, In : Journal of women's health (2002). 18, 12, p. 2041-2047 7 p.

Research output: Contribution to journalArticle

41 Scopus citations